AminoChain, a New York-based blockchain platform developer, has raised $5 million in seed funding to further its mission of connecting medical institutions globally through decentralized applications.
- Funding: AminoChain raised $5M in seed funding, led by Andreessen Horowitz and Cercano. This brings the total funding to $7M, supporting future growth and development.
- Purpose: Funds will expand operations and speed up platform development.
- Founder: Founded by Caspar Barnes, AminoChain connects global inventories of bio-samples and research data.
- Compliance: HIPAA & GDPR compliant for secure, scalable healthcare data sharing.
AminoChain is on a mission to revolutionize healthcare data sharing, with this funding driving expansion and innovation.